In a 575-user study across four countries, 39% reported nails lifting versus 9% of controls. A companion study also found more hair loss and scalp redness.
Recap by typeshit. Full story at Medical Independent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
An Emory-linked abstract shown in Nashville found the link in past records. The authors say it isn't peer reviewed and patients shouldn't change medication over it.
The Vancouver firm says its patch aims to skip needles and refrigeration, and it plans a further update once testing results are in. No outcome data yet.
Loading…